Day: June 24, 2021
Blue Skyre brings deep facilities management expertise to meet client needs
ATLANTA, June 24, 2021 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management company Colliers (NASDAQ and TSX: CIGI) today announced a global partnership with Blue Skyre IBE, LLC (“Blue Skyre”) to accelerate the growth of an innovative Facilities Management (“FM”) Advisory offering. Colliers’ differentiated advisory and consulting service helps clients improve their internal FM capabilities and organizational models, enhance supply chain performance by utilizing multiple FM service providers, and implement agile technology solutions. This global service offering benefits from Colliers’ independent position in the FM space and expands upon the FM advisory and consulting services already provided across Colliers’ Europe, Middle...
South Africa’s Vox Chooses Minim Cloud Software to Deliver Its Next-Gen Home WiFi Experience
Written by Customer Service on . Posted in Public Companies.
Leading regional service provider will use Minim software platform to manage and secure subscriber networks with MikroTik routers and power the Vox Wi-Fi Home Manager App
MANCHESTER, NH and JOHANNESBURG, June 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Minim, Inc. (OTCQB: MINM), the creator of innovative internet access products, today announced that Vox has chosen Minim’s AI-driven cloud software platform, mobile app, and customer care portal to underpin the Vox Wi-Fi Home Manager, an easy to use mobile app offering full Wi-Fi management, visibility, threat detection and device management. Wi-Fi Home Manager will initially be available to all Vox customers with the MikroTik hAP AC ² router, a popular choice for home WiFi in South Africa, and bundled in with all Fiber To The Home (FTTH) sales. The Vox network targets 400,000...
Angus Gold Appoints David Cobbold to its Board of Directors
Written by Customer Service on . Posted in Public Companies.
TORONTO, June 24, 2021 (GLOBE NEWSWIRE) — Angus Gold Inc. (TSX-V: GUS | OTC: ANGVF) (“Angus” or the “Company”) is pleased to announce that Mr. David Cobbold will be joining the Company’s Board of Directors effective June 30, 2021.
Mr. Cobbold is a veteran mining investment banker with 23 years of financial services experience. Currently, he is a Managing Director and Head of Mining at Macquarie Capital Markets Canada where he is responsible for sourcing and leading merger, acquisition, sale and defense transactions for clients ranging from exploration and development companies to global metals & mining companies. David’s clients are based in Canada, US, U.K, South African and Australia. In addition, David has extensive experience in global commodity and securities markets. Prior to joining Macquarie, David worked at CIBC World...
CloudMD Closes Acquisition of VisionPros, a Rapidly Growing Digital Eyewear Platform
Written by Customer Service on . Posted in Mergers And Acquisitions.
VisionPros had revenue surpassing $22 million with Adjusted EBITDA margin exceeding 10% during 2020
VANCOUVER, British Columbia, June 24, 2021 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology company revolutionizing the delivery of care, is pleased to announce that it has closed the previously announced acquisition of VisionPros1, a vertically integrated digital eyewear platform that has serviced almost 1 million unique customers across North America.
VisionPros conveniently delivers contact lenses and glasses right to their customer’s door, anywhere in North America, and at a fraction of the cost of traditional retail optical stores. The highly scalable business model includes a rapidly growing, e-commerce platform and innovative...
Vera Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
Written by Customer Service on . Posted in Public Companies.
Completed an initial public offering with net proceeds, including the exercise of the underwriters’ option in full, of approximately $48.4 million in May 2021 – – –Expanded the management team to support initiation of atacicept clinical development program– – –Initiated Phase 2b ORIGIN clinical trial of atacicept in patients with IgA nephropathy (IgAN)
SOUTH SAN FRANCISCO, Calif., June 24, 2021 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today reported its financial results for the first quarter ended March 31, 2021, and provided a corporate update.
“Over the past nine months, we completed two capital raises for a total of...
VSBLTY Partners with RapidSOS to Deliver Threat Detection Data to 911
Written by Customer Service on . Posted in Public Companies.
• VSBLTY announces a partnership with RapidSOS and is now recognized as RapidSOS Ready• Through this partnership, VSBLTY sends life-saving emergency data directly to 911 through the RapidSOS Platform in an emergencyPhiladelphia, PA, June 24, 2021 (GLOBE NEWSWIRE) — VSBLTY Group Technologies Corp. (CSE: VSBY) (Frankfurt 5VS) (OTC: VSBGF) (“VSBLTY”), a leading provider of security and analytics technology, and RapidSOS announced today a partnership to provide first responders and 911 telecommunicators with the ability to access incident data from its industry-leading Vector™ software through RapidSOS. Built in partnership with public safety, RapidSOS’s emergency response data platform securely links life-saving data from over 350M connected devices directly to over 4,800 Emergency Communications Centers...
Miromatrix Medical Announces Pricing of Upsized Initial Public Offering
Written by Customer Service on . Posted in Public Companies.
EDEN PRAIRIE, Minn., June 24, 2021 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (Nasdaq: MIRO) (“Miromatrix”), a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives, today announced the pricing of its initial public offering of 4,800,000 shares of common stock at a price to the public of $9.00 per share. In addition, Miromatrix has granted the underwriter a 30-day option to purchase up to an additional 720,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. The common stock is expected to begin trading on The Nasdaq Capital Market under the ticker symbol “MIRO” on June 24, 2021, and the offering is expected to close on June 28, 2021, subject to the satisfaction...
Fulcrum Therapeutics Announces Results from ReDUX4 Trial with Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) Demonstrating Slowed Disease Progression and Improved Function
Written by Customer Service on . Posted in Public Companies.
Primary endpoint, change in DUX4-driven gene expression which was included as an experimental biomarker, was not met
Losmapimod showed statistically significant* (p
Sugarbud Expands Product Portfolio In Ontario
Written by Customer Service on . Posted in Public Companies.
CALGARY, Alberta, June 24, 2021 (GLOBE NEWSWIRE) — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.DB, SUGR.WR, SUGR.WS, SUGR.WT,) (OTCQB: SBUDF) (“Sugarbud” or the “Company”) is pleased to announce the expansion of the Company’s product portfolio in Ontario with the launch of Mule Fuel.
Mule Fuel is a very unique high-potency, high-terpene phenotype with a total THC range between 18-24% and terpene profiles between 3-5%.
Learn More About The Sugarbud Craft Cannabis Collection Here
“We are delighted to be expanding our Craft Cannabis Collection in the Province of Ontario – Canada’s largest and fastest growing recreational cannabis market,” stated Sugarbud’s CEO, John Kondrosky. “In addition to providing Ontario consumers with the potency profiles they are asking for, Mule Fuel is yet...
Aileron Therapeutics to be Added to the Russell Microcap® Index
Written by Customer Service on . Posted in Public Companies.
BOSTON, June 24, 2021 (GLOBE NEWSWIRE) — Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, announced today that it is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the U.S. market opens on June 28, 2021.
Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
“Protection against chemotherapy-induced toxicities represents a significant, largely unaddressed need in the oncology space, and one for which there is...